Scientists at UMass Chan Medical School in Worcester have developed a web application which will allow researchers and public health officials to track variants and clinical information about COVID-19 in Central Massachusetts, the medical school said on Thursday.
Medical device manufacturer Boston Scientific Corp., based in Marlborough, has received authorization to expand instructions for use labeling for its WATCHMAN FLX Left Atrial Appendage Closure device.
Avenge Bio, Inc., a Natick biotechnology company, announced on Monday that a paper has been published on the efficacy of its LOCOcyte immunotherapy platform, which is used to administer treatments to solid tumors.
Saint Vincent Hospital in Worcester is the first hospital in Central Massachusetts to offer aquablation treatment for people with enlarged prostates, the hospital announced on Monday.
As of Tuesday, the U.S. Centers for Disease Control reported 228 monkeypox cases in Massachusetts, a number much higher than any other state in New England.
Quinsigamond Community College in Worcester was awarded a $499,815 Skills Capital Grant from the Commonwealth of Massachusetts to update three nursing labs.
New Jersey-based pharmaceutical company PTC Therapeutics, Inc. has received marketing authorization from the European Commission for a gene therapy treatment manufactured in partnership with MassBiologics of UMass Chan Medical School in Worcester.